Free Trial
NYSEARCA:IDNA

iShares Genomics Immunology and Healthcare ETF (IDNA) Price, Holdings, & News

$23.93
-0.38 (-1.56%)
(As of 09/6/2024 ET)
Today's Range
$23.81
$24.42
50-Day Range
$22.86
$25.49
52-Week Range
$17.33
$25.70
Volume
11,615 shs
Average Volume
34,273 shs
Market Capitalization
$139.99 million
Assets Under Management
$136.30 million
Dividend Yield
0.59%
Net Expense Ratio
0.47%
IDNA stock logo

About iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.

IDNA Stock Price History

IDNA ETF News Headlines

iDNA Genomics Public Ltd
iShares Genomics Immunology and Healthcare ETF (IDNA)
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…
IDNA: Healthcare Dashboard For February
IBRN iShares Neuroscience and Healthcare ETF
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…
IDNA ETF Stock Price History
See More Headlines
Receive IDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Genomics Immunology and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
iShares
Fund Name
iShares Genomics Immunology and Healthcare ETF
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:IDNA
Inception Date
6/11/2019
Fund Manager
Jennifer Hsui, Greg Savage, Paul Whitehead
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
NYSE FactSet Global Genomics and Immuno Biopharma Index
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
61

Fund Statistics

Assets Under Management
$136.30 million
Average Daily Volume
$0.00
Discount/Premium
0.02%

Administrator, Advisor and Custodian

Administrator
State Street Bank and Trust Company
Advisor
BlackRock Fund Advisors
Custodian
State Street Bank and Trust Company
Distributor
BlackRock Investments, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
N/A
Short Interest
11,800 shs

Miscellaneous

Beta
1.14
Creation Unit
50,000
Creation Fee
$850.00
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

iShares Genomics Immunology and Healthcare ETF Expenses

TypeIDNATheme ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.47%0.57%0.55%0.51%0.52%
Other Expenses0.00%0.57%0.49%0.58%0.54%
Total Expense0.47%0.73%0.71%0.74%0.71%
Fee Waiver0.00%-0.74%-0.53%-0.68%-0.58%
Net Expense0.47%0.59%0.61%0.58%0.59%

iShares Genomics Immunology and Healthcare ETF (IDNA) Holdings & Exposure

IDNA Sector Exposure

IDNA Industry Exposure


IDNA ETF - Frequently Asked Questions

How have IDNA shares performed this year?

iShares Genomics Immunology and Healthcare ETF's stock was trading at $23.01 at the start of the year. Since then, IDNA stock has increased by 4.0% and is now trading at $23.93.
View the best growth stocks for 2024 here
.

How do I buy shares of iShares Genomics Immunology and Healthcare ETF?

Shares of IDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of iShares Genomics Immunology and Healthcare ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that iShares Genomics Immunology and Healthcare ETF investors own include Pfizer (PFE), Gilead Sciences (GILD), Intel (INTC), AbbVie (ABBV), Inovio Pharmaceuticals (INO), Novavax (NVAX) and Canadian Natural Resources (CNQ).

This page (NYSEARCA:IDNA) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners